Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated Melanomas.

Journal: The Journal of investigative dermatology
Published Date:

Abstract

Image-based analysis as a method for mutation detection can be advantageous in settings when tumor tissue is limited or unavailable for direct testing. In this study, we utilize two distinct and complementary machine-learning methods of analyzing whole-slide images for predicting mutated BRAF. In the first method, whole-slide images of melanomas from 256 patients were used to train a deep convolutional neural network to develop a fully automated model that first selects for tumor-rich areas (area under the curve = 0.96) and then predicts for mutated BRAF (area under the curve = 0.71). Saliency mapping was performed and revealed that pixels corresponding to nuclei were the most relevant to network learning. In the second method, whole-slide images were analyzed using a pathomics pipeline that first annotates nuclei and then quantifies nuclear features, showing that mutated BRAF nuclei were significantly larger and rounder than BRAF‒wild-type nuclei. Finally, we developed a model that combines clinical information, deep learning, and pathomics that improves the predictive performance for mutated BRAF to an area under the curve of 0.89. Not only does this provide additional insights on how BRAF mutations affect tumor structural characteristics, but machine learning‒based analysis of whole-slide images also has the potential to be integrated into higher-order models for understanding tumor biology.

Authors

  • Randie H Kim
    Ronald O. Perelman Department of Dermatology, Grossman School of Medicine, New York University, New York, New York, USA; Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA.
  • Sofia Nomikou
    Department of Pathology, NYU Grossman School of Medicine, New York, New York.
  • Nicolas Coudray
    Applied Bioinformatics Laboratories, NYU Grossman School of Medicine, New York, NY, USA. nicolas.coudray@nyulangone.org.
  • George Jour
    Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA. George.Jour@nyulangone.org.
  • Zarmeena Dawood
    Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA.
  • Runyu Hong
    Institute for Systems Genetics, Grossman School of Medicine, New York University, New York, New York, USA.
  • Eduardo Esteva
    Department of Biomedical Engineering, Tandon School of Engineering, New York University, New York, New York, USA.
  • Theodore Sakellaropoulos
    Department of Pathology, NYU School of Medicine, New York, NY 10016, USA; Laura and Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY 10016, USA.
  • Douglas Donnelly
    Laura and Isaac Perlmutter Cancer Center, Grossman School of Medicine, New York University, New York, New York, USA.
  • Una Moran
    Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA.
  • Aristides Hatzimemos
    Ronald O. Perelman Department of Dermatology, Grossman School of Medicine, New York University, New York, New York, USA.
  • Jeffrey S Weber
    Perlmutter Cancer Center, NYU Langone Health, New York, New York.
  • Narges Razavian
    1 Department of Computer Science, New York University , New York, New York.
  • Iannis Aifantis
    Department of Pathology, NYU School of Medicine, New York, NY 10016, USA; Laura and Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY 10016, USA.
  • David Fenyö
    Department of Biochemistry and Molecular Pharmacology, Institute for Systems Genetics, New York University Grossman School of Medicine, New York, USA.
  • Matija Snuderl
    Department of Pathology, New York University, New York, NY, USA.
  • Richard Shapiro
    Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA; Department of Surgery, Grossman School of Medicine, New York University, New York, New York, USA.
  • Russell S Berman
    Division of Surgical Oncology, Department of Surgery, NYU Grossman School of Medicine, New York, NY, USA.
  • Iman Osman
    Departments of Dermatology, Medicine, and Urology, NYU School of Medicine, New York, New York.
  • Aristotelis Tsirigos
    Department of Pathology, NYU School of Medicine, New York, NY 10016, USA; Laura and Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY 10016, USA; Applied Bioinformatics Laboratories, NYU School of Medicine, New York, NY 10016, USA. Electronic address: aristotelis.tsirigos@nyulangone.org.